溶栓治疗在基层医院的优势

The Advantages of Thrombolytic Therapy in Primary Hospital

目的观察尿激酶溶栓治疗急性心肌梗死的效果和心脏事件的情况。方法 64例急性心肌梗死病人依发病到就诊时间的早晚分为尿激酶溶栓组和非溶栓组,溶栓组以150万U尿激酶静脉溶栓,非溶栓组给予一般治疗,1周后做冠状动脉造影观察冠状动脉再通情况并记录心脏事件。结果静脉溶栓组血管再通率67.7%,非溶栓组血管再通率27%,溶栓组心功能损害较非溶栓组轻。结论静脉溶栓治疗仍可以是基层医院治疗急性心肌梗死的主要方法 ,转院将延误再灌注治疗。

Objective The study is to observe the effect of thrombolysis therapy with urokinase to acute myocardial infarction （ AMI） and the occurrence of heart attacks. Methods 64 patients with acute Myocardial infarction were divided randomly in 2 groups and treated differently with Urokinase and un-urokinase medicine. The group with intravenous thrombolysis was treated with 1. 5 million units urokinase and another group with general medicine the 64 patients all underwent coronary artery angiographies later to evaluate the restoration of blood flow of infarct-related artery and record the heart events. Results The reperfusion rate of intravenous thrombolysis is 67. 7% while 27% in another group and the proportion of heart failure is lower in the group with intravenous thrombolysis. Conclusion The intravenous thrombolysis therapy should be an important method to AMI in primary hospital,the delaying result from changing hospital will affect the reperfusion.